Blood thinner safety under the microscope: 2,000 heart patients enrolled

NCT ID NCT04347200

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry is following 2,000 people with chronic coronary artery disease who are taking long-term blood thinners (antiplatelet or anticoagulant drugs). The goal is to track how often serious bleeding or clotting events (like heart attacks or strokes) occur. By understanding these risks, doctors may be able to tailor treatment more safely for each patient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Antiplatelet or anticoagulant drugs (blood thinners)
What this could lead to
If successful, this could help doctors better balance the risks of bleeding and clotting when prescribing long-term blood thinners for heart disease patients.
What could go wrong
This is an observational registry, not a treatment trial, so it won't test a new drug or cure. Results may not apply to all patients or lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) (E.G., ANGINA, MYOCARDIAL INFARCTION, AND ATHEROSCLEROTIC HEART DISEASE (ASHD)) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

    RECRUITING

    Moscow, 121552, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.